Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease - Summary - MDSpire

Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease

  • By

  • Hao Xu

  • Dun Li

  • Jie Liang

  • Nathan Adamson

  • Alexis Scherl

  • Luli Zou

  • Crystal Hu

  • Elaine E. Storm

  • Christian B. Cox

  • Adam Johnson

  • Mary E. Keir

  • Hua Zhang

  • Saiyu Hang

  • June 9, 2026

  • 0 min

Share

Objective:

To investigate the role of NF-κB-inducing kinase (NIK) in inflammatory bowel disease (IBD) pathogenesis.

Key Findings:
  • NIK deletion in epithelial cells disrupted M-cell differentiation and reduced recruitment of Th17 cells.
  • NIK activity in dendritic cells amplified CD40-mediated innate immune responses.
  • NIK skewed T cell differentiation toward pro-inflammatory Th1 cells, reducing regulatory T cells.
  • Systemic NIK deletion and pharmacologic inhibition with NIK-smi reduced inflammation and improved colon histopathology in preclinical models.
  • Optimal dosing regimen for NIK-smi was identified as 200 mg/kg BID.
Interpretation:

Limitations:
  • The study primarily utilized preclinical models, which may not fully replicate human IBD.
  • The long-term effects and safety of NIK inhibition in humans remain to be established.
Conclusion:

Original Source(s)

Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease

  • by Hao Xu, Dun Li, Jie Liang, Nathan Adamson, Alexis Scherl, Luli Zou, Crystal Hu, Elaine E. Storm, Christian B. Cox, Adam Johnson, Mary E. Keir, Hua Zhang, Saiyu Hang

  • June 9, 2026

Related Content

Renal Conditions Associated with Inflammatory Bowel Disease: Exploring Clinical Links, Shared Mechanisms, and Management Approaches

Evidence-based summary of optimal home self-management for elderly ostomy patients

Distinct microbial mediators link diet to inflammation in Crohn’s disease and ulcerative colitis